بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
-
1801
Data Sheet 2_Increasing Mu wave desynchronization after dance classes on people with Parkinson’s disease.pdf
منشور في 2025"…The results showed a statistically significant increase in Mu rhythm desynchronization in the alpha 1 band at the central channels after 6 months of dance classes. …"
-
1802
-
1803
-
1804
-
1805
-
1806
Global burden of disease dataset.
منشور في 2025"…<div><p>Background</p><p>Chronic kidney disease (CKD) poses a significant global health challenge; however, its burden on pediatric populations remains underexplored. …"
-
1807
-
1808
-
1809
-
1810
-
1811
-
1812
-
1813
-
1814
-
1815
MXene/Bi<sub>2</sub>O<sub>3</sub> Nanocomposites as Supercapacitors for Portable Electronic Devices
منشور في 2025الموضوعات: -
1816
-
1817
Coronary heart disease framework diagram.
منشور في 2025"…<div><p>Coronary heart disease (CHD) is a major cardiovascular disorder that poses significant threats to global health and is increasingly affecting younger populations. …"
-
1818
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
منشور في 2025"…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
-
1819
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
منشور في 2025"…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
-
1820
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
منشور في 2025"…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"